Galixir is an artificial intelligence technology to promote the research and development of new drugs.
Funding reportedLast round: Series A
What company datasets say Galixir raised
Funding, as reported
Reported in all10Min the source's currency
Rounds2
Last roundSeries A
Last round dateDec 2020
Investors listed5
Artificial Intelligence (AI) in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Galixir in front of investors. Or tell us what we have wrong.